PHENTERMINE HYDROCHLORIDE
PHENTERMINE HYDROCHLORIDE
Approval overview PHENTERMINE HYDROCHLORIDE is listed in Drugs@FDA under application 204663 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PHENTERMINE HYDROCHLORIDE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 30MG Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2017-06-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview PHENTERMINE HYDROCHLORIDE is listed in Drugs@FDA under application 204663 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PHENTERMINE HYDROCHLORIDE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 30MG Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2017-06-28 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.